Once a leading European destination for international patients, Germany is confronting a combination of changing source markets, legal constraints, hospital pressures and stronger global competition
Germany's position in international medical tourism has changed substantially since the boom years of the 2000s and early 2010s. The country continues to attract foreign patients and retains a strong reputation for specialist medicine, but the high-value business built around self-paying and state-sponsored patients from Russia, the Gulf and other non-EU markets has weakened.
The reasons go considerably beyond price competition from destinations such as Turkey. Historical patient data, changes in German healthcare law and developments within the hospital system point to a broader structural transformation. Declining demand from important source markets has coincided with tighter rules surrounding patient referrals, greater payment risks and growing pressure on German hospitals themselves.
Patient numbers hide a changing market
Germany recorded around 255,000 foreign patients in 2015. The figure slipped to approximately 253,000 in 2016 and 247,500 in 2017, while annual revenues remained around €1.2 billion.
Those headline numbers, however, do not fully describe what happened to the market. By 2018, almost two-thirds of foreign patients were coming from other EU countries, with Poland particularly important. This includes substantial cross-border and outpatient activity, which differs economically from the longer-distance, high-value medical travel that previously encouraged hospitals to establish dedicated international departments.
The result is an important distinction for the health tourism industry. Germany has not ceased treating international patients, but the composition and commercial value of that business have changed.
Russia and the Gulf lost momentum
Russia was once one of Germany's most important medical tourism source markets. From 2014 onwards, the weaker rouble, lower oil prices and EU sanctions made German treatment increasingly expensive for Russian patients. The war against Ukraine from 2022 subsequently added banking restrictions, disrupted air connections and political barriers.
Several Gulf markets also contracted. Government spending constraints and changing policies towards overseas treatment reduced patient flows, while greater scrutiny of hospital invoices affected relationships between German providers and public payers.
Kuwait offers a striking example. Patient numbers from the country fell by 62% within a single year, while Saudi Arabia and Oman also recorded substantial declines.
These changes removed two of the international markets that had made medical tourism particularly attractive for German hospitals.
Trust became an increasingly important issue
Financial disputes and controversial billing practices added another problem. One prominent case involved the treatment of approximately 370 Libyan war casualties at a Stuttgart teaching hospital, which resulted in a deficit of around €9 million. Other controversies concerned the handling and billing of patients financed through Gulf states.
For international medical tourism, such cases have consequences beyond the institutions directly involved. Government agencies and embassies sending significant numbers of patients depend on predictable costs, transparent billing and confidence in their provider networks.
Once that confidence weakens, countries can redirect patients to competing destinations or invest more heavily in treatment at home.
German law changed the patient-acquisition model
Germany's regulatory environment has meanwhile made traditional commission-based patient referral considerably more difficult.
Sections 299a and 299b of the German Criminal Code, introduced in 2016, extended anti-corruption provisions within healthcare. They do not prohibit cooperation with international patient facilitators as such, but benefits connected with patient referrals can create criminal-law risks depending on how an arrangement is structured.
German civil law has created an additional obstacle. A 2011 ruling by the Regional Court of Kiel concerned an arrangement under which a doctor with contacts in Gulf countries was to receive between 15% and 22.5% of hospital revenue for referring private patients from Oman and the United Arab Emirates. The commission agreement was held to be void.
A Regional Court of Stuttgart decision in 2024 reinforced the restrictive approach to patient-referral commissions and also addressed arrangements combining brokerage with additional services such as interpreting and visa assistance.
For medical tourism providers, this does not mean that international patient acquisition is impossible. It does mean that cooperation between hospitals, facilitators and other intermediaries requires substantially greater legal care than the commission-driven models common during the sector's earlier expansion.
Hospitals have different priorities
At the same time, conditions inside Germany's healthcare system have changed.
International patients are commercially attractive when hospitals have sufficient beds, medical personnel and administrative capacity. Staff shortages and financial pressure alter that calculation. A foreign self-paying patient may generate additional revenue, but international cases can also require extensive coordination, language services and administrative support.
During the pandemic, some hospitals deliberately restricted international admissions. Hamburg's university hospital was reported to have decided not to occupy beds with foreign patients, while international business at a major Munich university hospital largely came to a halt. Düsseldorf University Hospital subsequently stopped actively targeting international patients, and Berlin hospital group Vivantes closed its central international medicine unit.
These developments point to a supply-side issue that is sometimes overlooked in discussions about medical tourism. A destination needs not only international demand but also hospitals that actively want the business.
Changing physician incentives add another dimension
The economics have also changed at physician level.
Traditionally, some German chief physicians held personal billing rights that allowed them to receive income directly from privately insured or self-paying patients. International private patients could therefore provide a significant financial incentive for senior specialists.
Newer employment contracts increasingly replace this model with remuneration systems in which the hospital retains the billing rights and the physician receives a share of the proceeds instead.
That contractual shift is relevant to medical tourism because renowned specialists have historically been important drivers of international demand. Patients frequently travel not simply for a hospital brand but for a particular surgeon or physician.
If the individual financial incentive declines while hospitals themselves become less interested in international cases, both sides of the former growth model weaken.
Turkey and other destinations compete for international patients
Germany's internal changes have occurred while international competition has intensified.
Turkey has developed into a major medical tourism destination, while Gulf countries have expanded their own healthcare capacity and international partnerships. The competitive landscape has therefore changed considerably from the period when Germany's technological reputation and specialist expertise gave it a particularly strong position among affluent international patients.
Price is part of this competition, but it is not the only factor. Accessibility, international patient services, language support, transparent packages, uncomplicated payment processes and institutional commitment increasingly influence destination choice.
Germany still has assets for a medical tourism comeback
Germany's medical expertise, university hospitals, specialist centres and international reputation have not disappeared. The more fundamental question is whether the country still has the structures required to turn those strengths into a competitive international patient business.
The experience of the past decade suggests that medical excellence alone is insufficient. Successful inbound medical tourism also requires trusted relationships with source markets, legally robust patient-acquisition channels, secure payment mechanisms, specialised international departments and hospitals willing to commit personnel and capacity to foreign patients.
Germany therefore faces less a simple decline than a strategic decision. Rebuilding the high-value international patient market would require a different model from the one that drove its earlier medical tourism boom.
Image Credit: © AI generated illustration
